| Literature DB >> 33565253 |
Shuo Xu1, Dawen Guo2, Xintian Liu1, Xin Jin1, Yan Shi1, Yingbin Wang1, Nan Zhang1, Hong Zhang1.
Abstract
PURPOSE: Understanding the spectrum of ocular pathogens in a given geographic region is important for devising appropriate practical treatment. Therefore, we examined the pathogen spectrum and antibiotic resistance of microbial keratitis in northeast China.Entities:
Keywords: antibiotic resistance; microbial keratitis; ocular pathogen; surveillance
Mesh:
Substances:
Year: 2021 PMID: 33565253 PMCID: PMC9542897 DOI: 10.1111/aos.14789
Source DB: PubMed Journal: Acta Ophthalmol ISSN: 1755-375X Impact factor: 3.988
Predisposing factors of patients with microbial keratitis (n = 440).
| Predisposing factors | Amount of cases (%) |
|---|---|
| Trauma | 280 (63.64) |
| Vegetative materials | 152 (34.55) |
| Chemical or thermal injuries | 30 (6.82) |
| Scrap iron | 18 (4.09) |
| Sands | 12 (2.73) |
| Dusts | 12 (2.73) |
| Local irradiation | 13 (2.95) |
| Unidentified foreign bodies | 43 (9.77) |
| Ocular surgeries (cataract surgery, penetrating keratoplasty, pterygium excision) | 80 (18.18) |
| Ocular diseases | 48 (10.91) |
| Contact lens wear | 20 (4.55) |
| Unknown | 70 (15.91) |
Genus distribution of bacteria isolated from 2017 to 2019 in Harbin Ophthalmic Center.
| Genus | Specimens, |
|---|---|
| Gram‐positive organisms | 214 (83.27%) |
| Coagulase‐negative staphylococci (CNS) | 150 (58.37%) |
|
| 142 (55.25%) |
| Other CNS | 8 (3.12%) |
|
| 53 (20.62%) |
|
| 6 (2.33%) |
|
| 3 (1.17%) |
| Other: | 2 (0.78%) |
| Gram‐negative organisms | 43 (16.73%) |
|
| 10 (3.89%) |
|
| 7 (2.72%) |
|
| 6 (2.33%) |
|
| 6 (2.33%) |
|
| 5 (1.96%) |
| Other | 2 (0.78%) |
| Other: | 7 (2.72%) |
| Total | 257 (100.00%) |
Genus distribution of fungi isolated from 2017 to 2019 in Harbin Ophthalmic Center.
| Genus | Specimens, |
|---|---|
| Filamentous fungi | 23 (92.00%) |
|
| 10 (40.00%) |
|
| 6 (24.00%) |
|
| 4 (16.00%) |
| Penicillium | 1 (4.00%) |
| Curvularia | 1 (4.00%) |
| Cladosporium | 1 (4.00%) |
| Nonfilamentous fungi | 2 (8.00%) |
|
| 1 (4.00%) |
|
| 1 (4.00%) |
| Total | 25 (100.00%) |
Overall susceptibility rate of isolated Gram‐positive bacteria to different antibiotics in Harbin Ophthalmic Center.
|
| Coagulase‐negative staphylococci |
| |
|---|---|---|---|
| Oxacillin | 83.02% (44/53) | 36% (54/150) | / |
| Penicillin | / | / | 83.33% (5/6) |
| Cefepime | / | / | 100.00% (6.6) |
| Gentamicin | 81.13% (43/53) | 89.33% (134/150) | / |
| Ciprofloxacin | 81.13% (43/53) | 44.67% (67/150) | / |
| Levofloxacin | 81.13% (43/53) | 46.00% (69/150) | 100.00% (6/6) |
| Moxifloxacin | 81.13% (43/53) | 46.67% (70/150) | 100.00% (6/6) |
| Erythromycin | 24.53% (13/53) | 16.67% (25/150) | 0.00% (0/6) |
| Tetracycline | 88.68% (47/53) | 70.67% (106/150) | 33.33% (2/6) |
| Clindamycin | 28.30% (15/53) | 38.00% (57/150) | 0.00% (0/6) |
| Vancomycin | 100.00% (53/53) | 100.00% (150/150) | 100.00% (6/6) |
| Linezolid | 100.00% (53/53) | 100.00% (150/150) | 100.00% (6/6) |
Fig. 1Concurrent resistance to other antibiotic classes among ocular isolates by methicillin resistance phenotype. Isolates were tested concurrent resistance against clindamycin, tetracycline, erythromycin, moxifloxacin, levofloxacin, ciprofloxacin and gentamicin. MR = methicillin resistant; MS = methicillin susceptible.
Fig. 2Multidrug resistance among staphylococcal isolates. Isolates were tested against oxacillin, gentamicin, ciprofloxacin, erythromycin, tetracycline, clindamycin, vancomycin and linezolid. The percentage of resistance includes intermediate resistance. MR = methicillin resistant; MS = methicillin susceptible.
Overall susceptibility rate of isolated Gram‐negative bacteria to different antibiotics in Harbin Ophthalmic Center.
|
|
|
|
|
| |
|---|---|---|---|---|---|
| Cefepime | 100.00% (10/10) | 100.00% (7/7) | 83.33% (5/6) | 33.33% (2/6) | 100.00% (5/5) |
| Imipenem | 100.00% (10/10) | 100.00% (7/7) | 100.00% (6/6) | 50.00% (3/6) | 100.00% (5/5) |
| Gentamicin | 100.00% (10/10) | 57.14% (4/7) | 50.00% (3/6) | 33.33% (2/6) | 60.00% (3/5) |
| Tobramycin | 100.00% (10/10) | 57.14% (4/7) | 50.00% (3/6) | 50.00% (3/6) | 60.00% (3/5) |
| Ciprofloxacin | 90.00% (9/10) | 57.14% (4/7) | 50.00% (3/6) | 16.67% (1/6) | 80.00% (4/5) |
| Levofloxacin | 100.00% (10/10) | 85.71% (6/7) | 83.33% (5/6) | 50.00% (3/6) | 80.00% (4/5) |